ResMed partners EDB to expand Singapore operations

The company will increase its production capacity and advance its technology in Singapore.

ResMed has partnered with the Singapore Economic Development Board (EDB) to expand its operations in Singapore.

As part of its new investments in Singapore in 2029, ResMed will boost its production capacity, drive advanced manufacturing process innovation, and support the growth of its Digital Science and Artificial Intelligence (AI) Lab (DSAIL).

These investments and partnerships will boost ResMed’s advancements in sleep health, breathing health, and home health technology.

“We have been in Singapore for over two decades, and this EDB partnership reflects our ongoing commitment to leveraging Singapore’s exceptional digital infrastructure, talent, and technology to help us achieve our goal of improving the lives of 500 million people by 2030,” Mick Farrell, CEO of ResMed said.

ResMed currently provides 1,300 jobs in Singapore.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia